XV Eurasian Hematology-Oncology Congress - EHOC 2024
A

Luspatercept and Blood Transfusion Management in Beta Thalassemia and MDS

By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Anıl Tombak
By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Anıl Tombak
9 views
August 15, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

04:26
Pharmacosmos Hematology

An Introduction to an IV iron replacement therapy

Feat. H. Bahrain

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Related Content

AUTOPLAY
University of Utah Neurology

Postural Tachycardia Syndrome (POTS) & Beyond for Primary Care and S…

Fri, Oct 25, 2024
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
22:37
Insights from 2023 ASH Annual Meeting

AML and MDS Highlights & Key Takeaways

Feat. T. Badar
27:49
Insights from 2024 EHA Annual Meeting

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Feat. T. Badar
31:53
Indy Hematology Review

HSCT in 2024: What Every Hematologist Needs to Know

Feat. R. Childs
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
15:39
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

Thalassemias: Overview of Pathophysiology and Treatment

Feat. K. Fertrin
33:17
Indy Hematology Review

Managing Benign Hematology Disorders

Feat. C. Kessler
14:32
Vanderbilt University Medical Center (VUMC)

Summary of Recent Updates in MDS

Feat. S. Ball
16:55
Moffitt Cancer Center

Making Sense of the New Classification Systems for MDS in 2024

Feat. R. Komrokji
23:37
Rush University Medical Center

Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6

Feat. E. Bhaimia
12:15
Moffitt Cancer Center

Using Transplant in Patients With p53 Mutant MDS or AML

Feat. H. Elmariah
28:33
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

The Truth About Current Consensus Statements on Hematopoietic Cell T…

Feat. R. Gale
09:42
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based Gv…

Feat. M. Al Malki
04:16
UChicago Medicine 12th International Clinical Cancer Genomics Conference

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

Feat. L. Banaszak
13:26
Steven Pavletic

Chronic GvHD: Main Complications After ASCT

12:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Myeloid for Measure - New Therapeutics in…

Feat. A. Patel
32:04
Moffitt Cancer Center

Experts Discuss the Latest Data in Myeloid Diseases

Feat. A. Kuykendall, R. Komrokji, O. Chan, D. Sallman
25:38
Rush University Medical Center

Allo-HSCT Conditioning Regimens: Current Status and Future Directions

Feat. C. Brunstein
25:12
Rush University Medical Center

Bone Marrow Failure: The Importance of Mutational Testing

Feat. J. Shammo
44:26
University of Colorado Division of Hematology

Novel Therapies in AML and MDS

Feat. D. Pollyea